|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | ||||
| Depreciation | ||||
| Deferred tax benefit | ||||
| Amortization of operating lease right-of-use assets | ||||
| Share-based compensation | ||||
| Gain from disposal of testing vessel | ||||
| Change in fair value of convertible notes | ||||
| Loss on settlement of convertible notes | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Prepayments, prepaid expenses and other assets | ||||
| Due from related parties | ||||
| Accounts payable | ||||
| Advances from customers | ||||
| Accrued expenses and other liabilities | ||||
| Taxes payable | ||||
| Operating leases liabilities | ||||
| Net cash provided by (used in) operating activities | ||||
| Cash flows from investing activities: | ||||
| Additions to property and equipment | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Net cash acquired in the reverse recapitalization | ||||
| Repayment of loans to related parties | ||||
| Loans from related parties | ||||
| Repayment of long-term bank loans | ||||
| Cash received from warrants exercised | ||||
| Cash received from options exercised | ||||
| Capital contributed by shareholders | ||||
| Dividends to shareholders | ||||
| Proceeds from convertible notes | ||||
| Repayment of convertible notes | ||||
| Net cash (used in) provided by financing activities | ||||
| Net increase (decrease) in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of year | ||||
| Cash and cash equivalents, end of year | ||||
| Supplemental disclosure information: | ||||
| Cash paid for income taxes | ||||
| Cash paid for interest | ||||
| SUPPLEMENTAL DISCLOSURES OF NON-CASH ACTIVITIES | ||||
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | ||||
| Ordinary Shares issued for prepaid services – current portion | ||||
| Ordinary Shares issued for prepaid services – noncurrent portion | ||||
| Ordinary Shares issued for deferred compensation expense | ||||
| Ordinary Shares issued for deferred compensation expense– noncurrent portion | ||||
| Ordinary Shares issued for settlement of convertible notes | ||||
| Ordinary Shares issued for settlement of related party liabilities in a private placement | ||||
| Ordinary Shares issued for settlement of accrued liabilities and other payable | ||||
| Ordinary Shares issued for conversion of convertible notes | ||||
| Disposal of testing vessel through settlement of liabilities | ||||
| Conversion of rights to Ordinary Shares upon the reverse merger recapitalization | ||||
Loading...
